Authors
Loading...
Research demonstrates enhanced siRNA delivery with bifunctional antibodies in various cell types, indicating potential for broader therapeutic use.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: